IS DNA DESTINY?: A Cure for Cystic Fibrosis

This publication has 32 references indexed in Scilit:

• Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
  Cell, 1997
• Gene therapy for cystic fibrosis: steady progress, should do well
  European Respiratory Journal, 1997
• Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial
  Human Gene Therapy, 1997
• Modification of Nasal Epithelial Potential Differences of Individuals with Cystic Fibrosis Consequent to Local Administration of a Normal CFTR cDNA Adenovirus Gene Transfer Vector
  Human Gene Therapy, 1995
• Evaluation of Repeat Administration of a Replication Deficient, Recombinant Adenovirus Containing the Normal Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Airways of Individuals with Cystic Fibrosis. New York Hospital–Cornell Medical Center, New York, New York
  Human Gene Therapy, 1995
• Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
  Nature Medicine, 1995
• Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
  Nature Genetics, 1994
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
  Proceedings of the National Academy of Sciences, 1993
• Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice
  Nature Genetics, 1993
• Submucosal glands are the predominant site of CFTR expression in the human bronchus
  Nature Genetics, 1992